Highlights d Infection induces Qa-1b expression on B and T lymphocytes d Qa-1b promotes anti-viral immunity and prevents chronic viral infection d Qa-1b expression on B lymphocytes inhibits NK cellmediated regulation of T cells SUMMARY NK cells can reduce anti-viral T cell immunity during chronic viral infections, including infection with the lymphocytic choriomeningitis virus (LCMV). However, regulating factors that maintain the equilibrium between productive T cell and NK cell immunity are poorly understood. Here, we show that a large viral load resulted in inhibition of NK cell activation, which correlated with increased expression of Qa-1b, a ligand for inhibitory NK cell receptors. Qa-1b was predominantly upregulated on B cells following LCMV infection, and this upregulation was dependent on type I interferons. Absence of Qa-1b resulted in increased NK cell-mediated regulation of anti-viral T cells following viral infection. Consequently, anti-viral T cell immunity was reduced in Qa-1b-and NKG2Adeficient mice, resulting in increased viral replication and immunopathology. NK cell depletion restored anti-viral immunity and virus control in the absence of Qa-1b. Taken together, our findings indicate that lymphocytes limit NK cell activity during viral infection in order to promote anti-viral T cell immunity.
Correspondence langp@uni-duesseldorf.de In Brief Xu et al. show that Qa-1b expression is predominantly upregulated on B lymphocytes following lymphocytic choriomeningitis virus infection. Absence of Qa-1b results in increased NK cellmediated regulation of anti-viral T cells, limited anti-viral immunity, and chronic viral infection.
NK cell B cell
T cell Virus INTRODUCTION Innate lymphoid cells (ILCs) originate from a common lymphoid progenitor, but do not express B or T cell receptors. Based on their transcription factor and cytokine expression profiles, ILCs can be classified into several subsets, including natural killer (NK) cells, type 1 ILCs (ILC1s), ILC2s, ILC3s, and lymphoid tissue-inducer cells (LTis) (Eberl et al., 2015a (Eberl et al., , 2015b . Similar to cytotoxic CD8 + T cells, NK cells express Eomesodermin and T-bet, which can induce perforin, granzyme, and IFN-g expression (Gordon et al., 2012) . In contrast, non-cytotoxic ILC1s mainly express T-bet and produce IFN-g (Klose et al., 2014) . Transcription factor GATA-3 is required for ILC2 differen-tiation (Hoyler et al., 2012) . Activated ILC2s produce cytokines, such as IL-4, IL-5, and IL-13 (Eberl et al., 2015a) . Both ILC3s and LTis require RORgt for their development and produce similar cytokines, including IL-17, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-22 (Eberl et al., 2015a (Eberl et al., , 2015b . The anti-viral function of NK cells is well documented. NK cells can control infection induced by viruses, such as herpes simplex virus-1, influenza virus, ectromelia virus, and murine cytomegalovirus, through IFN-g production or cytotoxicity (Vivier et al., 2008) . Emerging evidence suggests that other ILC subsets also contribute to anti-viral defenses. IFN-g-producing ILC1s are critical in controlling mouse hepatitis virus (MHV) in Peyer's patches and mesenteric lymph nodes (Gil-Cruz et al., 2016) . The organization of secondary lymphoid organs after viral infection is mediated by LTis, hence improving the efficacy of immune responses against re-infections ( Scandella et al., 2008) . Similarly, ILC2s are important for the maintenance of airway epithelial integrity during influenza virus infection (Monticelli et al., 2011) . Interestingly, a recent study showed that ILC1s, ILC2s, and ILC3s are rapidly depleted during acute HIV-1 infection (Kløverpris et al., 2016) . Taken together, the evidence suggests that ILCs are important and are strictly regulated during viral infections.
Anti-viral T cell immunity is critical for overcoming viral infections as lack or dysfunction of T cells results in viral persistence (Wherry, 2011) . Previous studies have revealed that NK cells can play a dual role during viral infections. Despite the well-documented anti-viral functions of NK cells, they can also target virus-specific T cells during viral infection and contribute to the establishment of chronic viral infections (Cook and Whitmire, 2013; Lang et al., 2012; Waggoner et al., 2012) . NK cells can be activated through type I interferon (IFN-I) receptor signaling and exhibit perforin-mediated cytotoxicity (Biron et al., 2002; Kä gi et al., 1994) . This NK celldependent, perforin-mediated cytotoxicity inhibits anti-viral T cell immunity and promotes chronic viral infection (Lang et al., 2012; Waggoner et al., 2012) . IFN-I also triggers the expression of ligands for NK cell receptors on virus-specific T cells, shifting the equilibrium toward NK cell inhibition (Crouse et al., 2014; Xu et al., 2014) . The expression of ligands for the activating NK cell receptor NKp46 can be suppressed by IFN-I (Crouse et al., 2014) , and IFN-I induces the expression of major histocompatibility complex (MHC) class I and class Ib molecules, ligands for NK cell inhibitory receptors (Xu et al., 2014) . As a consequence, absence of IFN-I receptor (IFNAR) signaling in T cells results in increased susceptibility of antiviral T cells toward NK cell-mediated attack (Crouse et al., 2015a (Crouse et al., , 2015b . Consistently, deficiency of the transcription factor Nlrc5 in T cells, which centrally controls expression of MHC-I molecules, results in deletion of virus-specific T cells by NK cells following viral infection (Ludigs et al., 2016) . T cells also express CD48, a ligand for the NK cell inhibitory receptor and member of the signaling lymphocytic activation molecule (SLAM) family receptor 2B4. SLAM-family-receptordeficient mice exhibit defective anti-viral T cell immunity, mainly through effects mediated by 2B4 (Guo et al., 2016; Waggoner et al., 2010) . Despite the above mentioned studies, whether NK cell-mediated regulation of anti-viral T cells is itself modulated remains insufficiently studied.
The human MHC-Ib molecule HLA-E and the murine Qa-1b both bind to NKG2 family members: NKG2A, NKG2C, and NKG2E along with CD94 (Vance et al., 1999; Vance et al., 1998; Zeng et al., 2012) . The cytoplasmatic domain of NKG2A contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) that suppresses NK cell activity following ligand binding (Vance et al., 1998) . In contrast, NKG2C-CD94 transmits NK cell activation through binding of DAP12, which contains an immunoreceptor tyrosine-based activating motif (ITAM) (Lanier et al., 1998; Vance et al., 1999) . The affinity for HLA-E to the inhibitory CD94-NKG2A is higher than to the activating receptor CD94-NKG2C, suggesting that inhibitory signals could be dominating (Valé s-Gó mez et al., 1999) . In mice, NKG2A is detected on naive NK cells and activated T cells in contrast to NKG2C or NKG2E when detected with an anti-NKG2A/C/E antibody (Rapaport et al., 2015) . Qa-1b-deficient cells are targeted by NK cells when transferred into wild-type (WT) animals (Lu et al., 2007) , while CD94-deficient mice exhibit similar NK cell functions compared with WT animals (Orr et al., 2010) . However, CD94-deficient mice are highly susceptible to ectromelia virus. Using an overexpression model system, Fang et al. (2011) demonstrated that NK cells can recognize the Qa-1b-expressing infected cells via the activating receptor NKG2E-CD94. The inhibitory receptor CD94-NKG2A is expressed on activated T cells, and deletion of NKG2A results in over-activation of T cells, which can lead to apoptosis (Rapaport et al., 2015) . Despite these insights into the importance of Qa-1b and NK cell interaction, the role of Qa-1b during viral infection remains relatively unexplored.
In this study, we show that large viral doses increased the expression of Qa-1b on B lymphocytes. Lack of Qa-1b resulted in elevated NK cell-mediated regulation toward T cells following lymphocytic choriomeningitis virus (LCMV) infection. Consequently, Qa-1b-and NKG2A-deficient mice exhibited reduced T cell immunity and defective viral control. In addition, NK cell depletion could partially restore anti-viral T cell responses and alleviate pathology in the absence of Qa-1b.
RESULTS

NK Cell Activity Rapidly Decreases following Infection with a Large Viral Load
HIV infection can result in a decrease of ILC subsets (Kløverpris et al., 2016) . To investigate whether LCMV infection changes ILC populations, we characterized different ILC subsets early after infection ( Figure 1A ). Although the presence of NK cells and ILC subsets remained stable following infection with lower doses, we observed a rapid decline in NK cells, ILC1s, ILC2s, and LTis following infection with higher doses 2 days post-infection ( Figure 1B ). This observation was not restricted to spleen tissue, as we also observed a decrease of ILC1s following infection in liver tissue ( Figure 1C ), as well as a decrease of NK cells and ILC1s in the blood ( Figure 1D ). As expected, LCMV titers were significantly increased in the organs of animals infected with higher LCMV doses (Figures S1A-S1C). Next, we transferred negatively sorted CD8 + T cells from a mouse expressing a transgenic T cell receptor recognizing the LCMV peptide gp33 as a transgene (P14) (Pircher et al., 1989) into WT mice followed by low-and high-dose infection. Interestingly, we observed a reduced presence of transferred T cells at day 1 and day 2 post-infection, and this correlated with reduced viability of the T cells in high-dose-infected mice ( Figure 1E ). However, at day 4 post-infection, the increased amount and viability of transferred T cells relative to the earlier time points prompted us to speculate whether NK cell-mediated regulation of anti-viral T cells is inhibited throughout the course of infection.
Qa-1b Triggers Inhibition of NK Cells and ILC1s following LCMV Infection
To further investigate the underlying mechanism of NK cellmediated regulation of anti-viral T cells, we measured gene expression of activating and inhibitory NK cell receptor ligands in whole spleen tissue harvested 1 day after infection. In highdose-infected animals, genes encoding for NK cell receptor activating ligands were rather upregulated when compared with low-dose-infected animals ( Figure 2A ). Notably, some ligands, such as Cd23, showed lower expression levels when compared with low-dose-infected animals ( Figure 2A ). However, when we monitored gene expression of ligands for inhibitory receptors, we found H2-t23 to be increased in high-dose-infected animals ( Figure 2A ). Increased expression of Qa-1b overlapped with B cell markers in spleen tissue sections of infected animals (Figure 2B) . Using flow cytometry (FCM) analysis, increased Qa-1b protein expression was detected in both B and T cells after high-dose infection ( Figure 2C ). H2-t23 expression was also significantly increased in sorted B cells from the high-dose-infected animals ( Figure S2A ). However, H2-t23 gene and Qa-1b protein expression in the spleen was similar in control and infected mice following depletion of CD8 + or CD4 + T cells ( Figures  S2B-S2D ). On the other hand, B cell-deficient JhT À/À or B and T cell-deficient Rag1 À/À mice had reduced levels of H2-t23 transcripts and Qa-1b protein in spleen tissue after infection ( Figures  2D-2F ). Clodronate treatment did not alter Qa-1b expression on an mRNA or protein level (Figures 2E and 2F) . Collectively, these data suggest that Qa-1b is predominantly expressed on B cells. Notably, Qa-1b expression in spleen tissue was dependent on IFN-I, as lack of the receptor (IFNAR) abolished expression for Qa-1b after LCMV infection ( Figures S2E and S2F ). Next, we wondered whether Qa-1b expression on B cells might be an important checkpoint of NK cell-mediated regulation of anti-viral T cells. To test this, we infected control (H2-t23 +/+ or H2-t23 +/À ) and H2-t23 -/mice (henceforth referred to as Qa-1b -/mice) with LCMV. When we monitored NK cells and ILCs, we observed similar decreases in NK cell and ILC numbers between control and Qa-1b-deficient mice in spleen and liver tissue (Figures 3A and 3B) 1 and 2 days post-infection with high-dose LCMV. The expression of surface molecules between control and Qa-1b À/À mice was similar in NK cells and ILCs ( Figure S3A ).
Consistently, granzyme B and perforin expression was comparable in control and Qa-1b-deficient mice ( Figure S3B ). We mainly detected positive staining with an anti-NKG2A/C/E (clone: 20D5) antibody in NK cells and ILC1s (Figures 3C and S3C), while cells from NKG2A-deficient mice failed to show a positive signal ( Figure S3D ). These data suggest that NKG2A is predominantly expressed on NK cells and ILC1s. Next, we wondered whether NK-mediated regulation of anti-viral T cells could be modulated by Qa-1b. To test this, we transferred P14 + CD8 + T cells into control and Qa-1b-deficient mice. Interestingly, we observed reduced numbers of transferred LCMV-specific T cells in the absence of Qa-1b 2 days (A) Representative FCM plots (n = 6) and gating strategy of spleen ILCs in C56BL/6 mice are presented. Dead cells and Lin + (CD3, CD5, CD8, CD19, Ly-6G, TCRb, and FcεR1) cells were excluded, viable CD90.2 + CD45.2 + Lin À cells were defined by conventional NK cells (NK1.1 + RORgT À Eomes + ), ILC1s (NK1.1 + RORgT À Eomes À ), ILC2s (NK1.1 À RORgT À CD11b À GATA-3 + ), ILC3s (RORgT + CD4 À ), and LTis (RORgT + CD4 + ). (B-E) C56BL/6 mice were infected with low-dose (200 plaque-forming units [pfu]) or high-dose (2 3 10 6 pfu) LCMV WE. (B-D) ILC subsets in the spleen (B), liver (C), and blood (D) tissue were determined at indicated time points (n = 6). (E) 10 6 negatively sorted CD8 + T cells from P14 + CD45.1 + animals were transferred into CD45.2 + WT hosts followed by no infection or infection with low-or high-dose LCMV WE. Transferred P14 + cell number and viability were determined at the indicated time points (n = 4). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups. See also Figure S1 . (D-F) WT, JhT À/À , Rag1 À/À , clodronate-treated WT or Rag1 À/À animals were infected with high-dose LCMV WE, and 1 day after infection (D and E) H2-t23 expression levels in spleen tissue from WT or JhT -/animals (D) or WT, Rag1 À/À , clodronate treated WT or Rag1 À/À animals (E) were determined (n = 3-4).
(F) Sections of snap frozen spleen tissue were analyzed for Qa1, CD19, CD8, and F4/80 expression (n = 3-4; scale bar indicates 50 mm). See also Figure S2 .
post-infection ( Figure 3D ). Furthermore, the transferred LCMVspecific T cells exhibited reduced viability when compared with control mice ( Figure 3E ). When we co-cultured concanavalin-A-activated CD8 + T cells with NK cells, we observed that Qa-1b À/À CD8 + T cells were more susceptible toward NK cellmediated killing ( Figure 3F ). The Qa-1b binding peptide Qdm increased Qa-1b expression on B cells ( Figure 3G ). Interestingly, NK cell-mediated killing of T cells could be partially restored by adding Qdm-stimulated B cells ( Figure 3H ). Taken together, these data indicate that NK cells exhibit increased regulatory functions against T cells in the absence of Qa-1b.
Absence of Qa-1b Results in Limited T Cell Immunity and Increased Pathology NK cells can target anti-viral T cells and, as a consequence, contribute to immunopathology and the establishment of chronic viral infections (Cook and Whitmire, 2013; Lang et al., 2012; Waggoner et al., 2012) . Therefore, we monitored anti-viral T cell immunity over time in Qa-1b -/and control mice. As expected, Qa-1b -/mice exhibited reduced circulating LCMV-specific T cells following infection with LCMV ( Figure 4A ). Additionally, LCMV-specific T cells were reduced in spleen and liver tissue following LCMV infection ( Figure 4B ). NK cells may target antigen presenting cells, (A-E) Control animals (Qa-1b +/+ or Qa-1b +/À ) and Qa-1b À/À mice were infected with high-dose LCMV WE, and the splenic ILC subsets (A) and liver ILC subsets (B) were determined (n = 6). (C) NKG2A expression on NK and ILC1 cells were determined by staining with anti-NKG2A/C/E antibody (clone 20D5) (n = 4). (D and E) 10 6 negatively sorted CD8 + T cells from P14 + CD45.1 + animals were transferred into CD45.2 + control or CD45.2 + Qa-1b À/À hosts followed by infection with high-dose LCMV WE. (D) The number of transferred P14 + cells was determined 2 days post-infection (n = 3-4). (E) P14 + viability was measured by Annexin V and 7AAD 2 days post-infection (n = 3-4).
(F) Negatively sorted CD8 + T cells from control animals and Qa-1b À/À mice were stimulated with Concanavalin A, and 24 hr later, 1,000 activated CD45.2 + CD8 + T cells were co-incubated with IL-2-derived CD45.1 + WT NK cells at the indicated effector-to-target ratio. Following a 4-hour incubation, the viability of activated CD45.2 + CD8 + T cells was determined by 7AAD staining (n = 6). (G) Positively sorted CD19 + B cells from control animals and Qa-1b À/À mice were incubated with 100 mg/mL Qdm peptide (AMAPRTLLL), and Qa-1b expression on B cells was determined 24 hr later, 1 of 6 representative histograms is shown. (H) A total of 1,000 Concanavalin-A-activated cells of negatively sorted CD8 + T cells from Qa-1b À/À mice were co-incubated with IL-2-derived CD45.1 + WT NK cells at an effector-to-target ratio of 50:1 in the presence of 30,000 B cells from (G). Following a 4-hour incubation, the viability of activated CD45.2 + CD8 + T cells was determined by 7AAD staining (n = 6). Error bars show SEM; *p < 0.05, **p < 0.01; ns, not statistically significant between the indicated groups. See also Figure S3 . Control and Qa-1b À/À mice were infected with high-dose LCMV WE.
(A) Gp33-specific tetramer was determined in the blood at the indicated time points after infection (n = 7-9). (B) Gp33-specific tetramer in the spleen (left) and liver tissue (right) are shown 12 days post-infection. (C) (Top) Representative histograms of day 12 splenic gp33-specific tetramer or naive splenic CD8 + T cells are shown. (Bottom) Mean fluorescence intensity (MFI) of indicated molecules was quantified from day 12 splenic gp33-specific tetramer (n = 7-9). (D) At day 12 post-infection, splenocytes (left panel) or liver cells (right panel) were re-stimulated with the LCMV-specific epitope gp33, followed by staining for IFN-g (n = 7-9).
(E) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 7-9).
(legend continued on next page) such as dendritic cells, and therefore cause reduced T cell immunity in the absence of Qa-1b (Crome et al., 2013) . However, when we measured innate IFN-I production early during infection, we did not observe any differences ( Figure S4A ). Furthermore, we did not see differences between dendritic cell numbers in control and Qa-1b-deficient mice ( Figure S4B ). Also, expression of co-stimulatory molecules on dendritic cells (DCs) was increased following LCMV infection in control and Qa-1b À/À mice ( Figure S4C ). Consistently, LCMV titers were comparable in tissue harvested from control and Qa-1b-deficient mice at day 1 and 2 post-infection ( Figures S4D and S4E ). However, LCMV-specific T cells exhibited higher expression of PD-1, TIM-3, and 2B4 in Qa-1bdeficient mice compared with control animals, indicating an exhausted state ( Figure 4C ) (Wherry, 2011) . We observed no difference in the proportion of CD8 + T cells expressing IL7R and CD62L between control and Qa-1b À/À animals ( Figure S4F ), suggesting Qa-1b did influence the function of anti-viral T cells.
Consistently, cytokine production of CD8 + T cells was reduced following re-stimulation with LCMV-specific epitopes ( Figure 4D ). We also observed significantly reduced LCMV-specific T cells in the spleen of Qa-1b-deficient mice 4 and 8 days after infection ( Figures S5A-S5C ), although expression of surface molecules indicating an exhausted state was similar in control and Qa-1bdeficient mice ( Figure S5D ). At day 8 post-infection, we observed a significant increase in LCMV titers in the spleen ( Figure S5E ) and higher viral loads in several organs harvested from Qa-1b -/mice 12 days post-infection ( Figure 4E ). These findings were further supported with an increased amount of LCMV-infected cells in the liver tissue of Qa-1b -/mice when compared with control animals ( Figure 4F ). Furthermore, increased activity of alanine aminotransferase (ALT) was detectable in the blood stream, indicating elevated liver damage in Qa-1b -/mice ( Figure 4G ). In addition, expression of a-smooth muscle actin (a-SMA) was higher in the liver tissue of Qa-1b -/mice than in the liver tissue of control animals following LCMV infection ( Figure 4H ). Since we observed increased Qa-1b expression on B cells following LCMV infection, we reconstituted lethally irradiated C57BL/6 animals with mixed bone marrow from Qa-1b-deficient, B cell-deficient Jh À/À , B and T cell-deficient Rag1 À/À , and CD8 + T cell-deficient Cd8 À/À mice. We observed similar anti-viral T cell immunity in mice reconstituted with Qa-1b À/À : Cd8 À/À bone marrow when compared with the corresponding controls ( Figure S5F ). However, reduced antiviral T cell immunity was observed in Qa-1b À/À :Rag1 À/À and Qa-1b À/À :Jh À/À hosts when compared with the corresponding controls ( Figures 4I and 4J) . Consistently, increased viral titers were detected in organs harvested from hosts receiving either Qa-1b À/À :Rag1 À/À or Qa-1b À/À :Jh À/À bone marrow when compared with their corresponding controls ( Figures 4K and 4L) . These findings suggest that Qa-1b expression on B cells promotes anti-viral T cell immunity. Next, we wondered whether Qa-1b could affect the incidence of chronic viral infection. We infected control and Qa-1b-deficient mice with the chronic LCMV strain Docile and observed similarly reduced T cell frequencies in Qa-1b À/À mice when compared with control animals ( Figure 5A ). This was associated with increased PD-1 expression and reduced IL-7 receptor (IL-7R) expression, indicating that LCMV-specific T cells were in an exhausted state in the absence of Qa-1b ( Figure 5B ). Consistently, cytokine production by CD8 + T cells was reduced 75 days after infection ( Figure 5C ). NK cells not only target antiviral CD8 + T cells, but also virus-specific CD4 + T cells during viral infection (Waggoner et al., 2012) . Interestingly, LCMV-specific CD4 + T cells were also reduced in Qa-1b-deficient mice when compared with control animals (Figures 5D and 5E ). Hence, we observed prolonged LCMV in the sera of Qa-1b À/À mice when compared with control animals ( Figure 5F ). LCMV was still detectable in organs harvested from Qa-1b-deficient mice 75 days post-infection ( Figures 5G and 5H) . Taken together, these data indicate that LCMV-specific T cell immunity is reduced in Qa-1b-deficient mice, resulting in increased virus replication and pathology, including chronic viral infection.
Next, we wondered whether the absence of the Qa-1b-binding receptor NKG2A could recapitulate the effects of Qa-1b deficiency following LCMV infection. LCMV-specific T cells were also reduced in NKG2A-deficient mice ( Figure 6A ). Moreover, cytokine production was decreased in NKG2A-deficient Klrc1 À/À mice when compared with WT controls ( Figure 6B ). LCMV titers were increased following infection in the absence of NKG2A ( Figures  6C and 6D) . However, the effects we observed in NKG2A-deficient mice were not as prominent as those incurred by Qa-1b deficiency. This may be explained by a T cell-intrinsic role of NKG2A (Rapaport et al., 2015) . Notably, LCMV-specific T cells showed positive staining for anti-NKG2A/C/E (clone 20D5) in control and Qa-1b-deficient animals following LCMV infection, while this staining was absent in NKG2A-deficient mice, suggesting that LCMV-specific T cells express NKG2A ( Figures S5G and S5H) . To investigate the role of NKG2A on LCMV-specific T cells, we reconstituted lethally irradiated C57BL/6 mice with mixed bone marrow from Cd8 À/À and Klrc1 À/À mice. Following LCMV infection, we observed increased T cell immunity at 12 days post-infection in (F) Sections of snap frozen liver tissue from control and Qa-1b À/À mice 12 days post-infection were analyzed for LCMV nucleoprotein expression by immunohistochemistry; 1 representative image of n = 7-9 is shown (scale bar indicates 50 mm). (G) ALT activity in the serum of control and Qa-1b À/À mice was determined at 8 days post-infection (n = 7-9). (H) Sections of snap frozen liver tissue from control and Qa-1b À/À mice 12 days p.i were stained with a-smooth muscle actin (Alpha-SMA) antibodies (1 representative image of n = 7-9 is shown, scale bar indicates 100 mm).
(I-L) Bone marrow cells from control or Qa-1b À/À mice were mixed at a 1:1 ratio with bone marrow cells from Rag1 À/À or JhT À/À mice and were transferred into lethally irradiated WT mice. One month later, these mixed chimeric animals were infected with 2 3 10 5 LCMV WE, and splenocytes harvested 12 days after infection. (I) Gp33-specific tetramer + CD8 + T cells in the spleen were determined in Qa-1b À/À :Rag1 À/À and WT:Rag1 À/À reconstituted chimeras (left). IFN-g + CD8 + cells were measured in splenocytes from these animals following re-stimulation with the LCMV epitope gp33 (right). (J) Gp33-specific tetramer + CD8 + T cells in the spleen were determined in Qa-1b À/À :Jh À/À and WT:Jh À/À reconstituted chimeras (left). IFN-g + CD8 + cells were measured in these samples following restimulation with the LCMV epitope gp33 (right). (K and L) Virus titers were determined from spleen, liver, lung, and kidney tissue in (K) Qa-1b À/À :Rag1 À/À and WT:Rag1 À/À reconstituted chimeras and (L) Qa-1b À/À :Jh À/À and WT:Jh À/À reconstituted chimeras (n = 8). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups. See also Figures S4 and S5. hosts receiving the Cd8 À/À :Klrc1 À/À bone marrow when compared with hosts receiving the Cd8 À/À :WT bone marrow (Figure S5I ). ALT activity was increased following infection of NKG2Adeficient mice, indicating increased pathology during infection ( Figure 6E ). In addition, NKG2A-deficient mice demonstrated an increased expression of a-SMA, indicating a higher degree of fibrosis following LCMV infection ( Figure 6F ). Taken together, these data indicate that Qa-1b and its binding receptor NKG2A promote anti-viral T cell immunity and alleviate virus-mediated pathology following LCMV infection.
NK Cell Depletion Partially Restores Defective T Cell Immunity and Prevents Pathology in Qa-1b-Deficient Mice
Increased NK cell activation might limit CD8 + T cell immunity and prolong viral replication and pathology. NK cells can be depleted using an anti-NK1.1 antibody (clone: PK136) ( Figure S6A ). We tested whether depletion of NK cells can improve T cell immunity in Qa-1b-deficient mice. We transferred negatively sorted LCMV-specific T cells into NK cell-depleted and NK cell-competent Qa1b À/À and control mice. We observed that depletion of NK cells could rescue the increased susceptibility of P14 + T cells in Qa-1b-deficient mice ( Figure 7A ). Furthermore, depletion of NK cells resulted in the increased presence of LCMV-specific endogenous T cells in Qa-1b-deficient mice ( Figure 7B) . Moreover, LCMV-specific T cell immunity was increased in spleen tissue following NK cell depletion in Qa-1b-deficient animals ( Figure 7C ). Cytokine production after re-stimulation with LCMV-specific epitopes was elevated in the absence of NK cells in Qa-1b-deficient mice ( Figure 7C ). Consistent with previously published data (Cook and Whitmire, 2013; Lang et al., 2012; Waggoner et al., 2012) , T cell immunity was enhanced in NK Control and Qa-1b À/À were infected with 2 3 10 4 pfu LCMV Docile.
(A) Gp33-specific tetramer was measured in the blood at the indicated time points after infection (n = 4-6). (B) PD-1 (left) and IL-7R (right) expression on blood gp33-specific tetramer at the indicated time post-infection is shown (n = 4-6).
(C) At day 75 post-infection, splenocytes were re-stimulated with the LCMV epitope gp33, followed by measurement of IFN-g production (n = 4-6).
(D) Gp61-specifc CD4 + tetramer response in the blood at the indicated time points after infection was determined (n = 4-6).
(E) At day 75 post-infection, splenocytes were re-stimulated with the LCMV epitope gp61, followed by staining for IFN-g (n = 4-6).
(F) LCMV titers were measured in the blood at indicated time points following infection (n = 4-6).
(G) Virus titers were determined from spleen, liver, lung, kidney, spinal cord, and brain tissue 75 days post-infection (n = 4-6).
(H) Section of snap frozen liver tissue from control and Qa-1b À/À mice 75 days post-infection were analyzed for LCMV nucleoprotein expression by immunohistochemistry; 1 of 4-6 representative images is shown (scale bar indicates 50 mm). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups.
cell-depleted control mice when compared with NK cell-competent control mice. However, we did not observe a complete rescue in the spleens of Qa-1b-deficient mice by NK cell depletion, indicating that there might be other NK cell-independent factors contributing to diminished LCMV-specific T cell immunity in the spleen tissue of Qa-1b-deficient animals ( Figure 7C ). However, surface molecule expression showed reduced expression of PD-1, TIM-3, 2B4, and Lag-3 ( Figures 7D and S6B ). Furthermore, viral titers were reduced in Qa-1b-deficient animals following treatment with anti-NK1.1 antibodies ( Figure 7E ). We did not observe LCMV-infected cells in snap frozen liver tissue in control or Qa-1b-deficient animals following treatment with the NK cell-depleting antibody ( Figure 7F ). ALT activity was reduced in the absence of NK cells in both control and Qa-1bdeficient mice ( Figure 7G ). In addition, a-SMA staining was reduced in anti-NK1.1-treated Qa-1b-deficient mice when compared with NK cell-competent Qa-1b-deficient mice (Figure 7H) . Taken together, these data indicate that NK cell depletion can rescue defective T cell immunity in Qa-1b-deficient mice and accordingly prevent pathology in these animals.
DISCUSSION
In this study, we identified a critical role for Qa-1b in inhibiting NK cell activity following infection with LCMV. Lack of Qa-1b resulted in increased NK cell-mediated regulation of T cell immunity and consequently increased viral replication and pathology. Depletion of NK cells partially restored T cell immunity and alleviated pathology in this setting. Qa-1b can bind to the inhibitory NK cell receptor NKG2A-CD94 and to the activating NK cell receptor NKG2C-CD94 (Lanier et al., 1998; Vance et al., 1998) . However, only NKG2A appears to be expressed in murine NK cells and activated T cells in contrast to NKG2C or NKG2E (Rapaport et al., 2015) . Interestingly, deletion of CD94 results in increased susceptibility to ectromelia virus infections (Fang et al., 2011) . NKG2A-deficient mice are susceptible to ectromelia virus infections, suggesting that the effects of CD94 deficiency are transmitted by NKG2A-CD94 (Rapaport et al., 2015) . In our setting, hyperactive NK cells targeted virus-specific T cells following infection, which impaired anti-viral immunity. Notably, Qa-1b was mainly expressed on B cells after infection, suggesting that B cells govern the equilibrium between regulatory NK cell function and T cell activation (Rapaport et al., 2015) . Although NK cell depletion could only partially restore anti-viral T cell responses during LCMV infection, NK cell depletion rescued virus-mediated pathology, which suggests that NK cells are a critical component in the effects observed with Qa-1b deficiency.
In humans, the role of NK cells during chronic viral infection and the regulation of virus-specific T cells remain poorly Control (C57BL/6) and Klrc1 À/À mice were infected with high-dose LCMV WE. (A) Splenic gp33-specific tetramer was measured 12 days post-infection (n = 9-11). (B) At day 12 post-infection, splenocytes were re-stimulated with the LCMV-specific epitope gp33, followed by determination of IFN-g production (n = 9-11).
(C) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 9-11).
(D) Sections of snap frozen liver tissue from control and Klrc1 À/À mice 12 days post-infection were analyzed for LCMV nucleoprotein expression assessed by immunohistochemistry; 1 representative image of n = 7-8 is shown (scale bar indicates 50 mm).
(E) ALT activity in the serum of control and Klrc1 À/À mice was measured 8 days post-infection (n = 11-12).
(F) Sections of snap frozen liver tissue from control and Klrc1 À/À mice 12 days post-infection were stained with a-smooth muscle actin (Alpha-SMA) antibody; 1 of 7-8 representative images is shown (scale bar indicates 100 mm). Error bars show SEM; *p < 0.05; ns, not statistically significant between the indicated groups. See also Figure S5 . (B-H) NK cell-depleted and non-depleted control and Qa-1b À/À mice were infected with high-dose LCMV WE. (B) Gp33-specific tetramer was measured in the blood at the indicated time points after infection (n = 8-10; *p < 0.05, **p < 0.01, ***p < 0.001 between the control and Qa-1b À/À group; # p < 0.05, ### p < 0.001 between Qa-1b À/À and NK cell-depleted Qa-1b À/À animals).
(C) Twelve days post-infection, gp33-specific CD8 + T cells in the spleen were determined (left). IFN-g production was measured in response to incubation with the LCMV epitope gp33 (n = 8-10, right). (D) Representative histograms of the indicated surface molecules on splenic gp33-specific CD8 + T cells are shown (n = 8-10).
(E) Virus titers were determined from spleen, liver, lung, and kidney tissue 12 days post-infection (n = 8-10).
(F) Sections of snap frozen liver tissue from NK cell-depleted or non-depleted control or Qa-1b À/À mice 12 days post-infection were analyzed for LCMV nucleoprotein expression by immunohistochemistry; 1 representative image of n = 8-10 is shown (scale bar indicates 50 mm).
(legend continued on next page) understood. Human chronic viral infections with hepatitis B or hepatitis C virus lead to induced cytotoxicity of NK cells (Ahlenstiel et al., 2010; Oliviero et al., 2009; Rehermann, 2013) . This NK cell activation may be triggered by IFN-I (Ahlenstiel et al., 2010) , which can be produced by plasmacytoid DCs (pDCs) or Kupffer cells after sensing hepatitis C virus (HCV) RNA (Lau et al., 2013; Takahashi et al., 2010) . During infection with HCV, expression of NK cell inhibitory receptors and their corresponding ligands correlates with the elimination of HCV (Khakoo et al., 2004; Knapp et al., 2010; Paladino et al., 2007) . However, treatment with IFN-I results in immediate increases in ALT levels caused by NK cell-mediated virus elimination, suggesting a protective role of NK cells during viral-induced hepatitis (Ahlenstiel et al., 2011) . Furthermore, the reaction of NK cells to interferon treatment can serve as an indicator of effectiveness in patients suffering from HCV infection (Oliviero et al., 2013) and as a predictor of treatment outcome (He et al., 2006; Sarasin-Filipowicz et al., 2008) . During HCV and HBV infection, the activating NK cell receptors NKp30, NKp46, NKG2C, NKG2D, and CD122 and the inhibitory receptor NKG2A are upregulated (Rehermann, 2013) . Interestingly, the HCV peptide aa35-44 stabilizes the NKG2A binding HLA-E and consequently increases its expression and triggers inhibition of NK cells (Nattermann et al., 2005) . There are two polymorphisms of HLA-E, which only differ in one amino acid, an arginine (HLA-E*0101, HLA-E R ) or a glycine (HLA-E*0103, HLA-E G ) in position 107 with increased surface expression of HLA-E R polymorphism (Strong et al., 2003) . Interestingly, homozygous expression of HLA-E R correlates with clearance of HCV genotype 2 and 3 (Schulte et al., 2009) . As suggested by our data, increased HLA-E expression might reduce NK cell activity and promote virus-specific T cell immunity. Taken together, this study identifies Qa-1b to be predominantly upregulated on B cells during infection with LCMV. Furthermore, lack of Qa-1b resulted in NK cell-mediated diminished anti-viral T cell immunity and increased pathology, which was partially rescued with NK cell depletion.
EXPERIMENTAL PROCEDURES Mice
Qa-1b À/À , Klrc1 À/À , Rag1 À/À , JhT À/À , Ifnar1 À/À , and CD45.1 + P14 + mice were bred in a C57BL/6 background and maintained under specific pathogen-free conditions. Experiments were performed under the authorization of Landesamt f€ ur Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen (LANUV) in accordance with German law for animal protection. For Qa-1b À/À -related experiments, littermate controls (Qa-1b +/+ or Qa-1b +/À ) were used. For the rest of the animals, WT (C57BL/6) mice were used as controls. For chimera experiments, WT mice were irradiated with 10.5Gy. One day later, mice were reconstituted bone marrow cells from indicated donors.
Viruses
LCMV strain WE was originally obtained from F. Lahmann-Grube (Heinrich Pette Institute). LCMV strain Docile was originally obtained from Dr. C.J. Pfau (Troy, NY). Viruses were propagated in L929 cells as previously described (Welsh and Seedhom, 2008) . Virus titers were measured with a plaque-forming assay as previously described (Battegay et al., 1991) .
Cell Depletion
NK cells were depleted with intravenous (i.v.) injections of anti-NK1.1 (clone PK136) as previously described (Xu et al., 2014) . CD8 and CD4 cell were depleted with i.v. injections of anti-CD8 (clone YTS169.4) or anti-CD4 (clone YTS 191) as previously described (Lang et al., 2008; Pellegrini et al., 2011) . For depletion of macrophages, mice were treated with clodronate liposomes. Control mice were treated with empty control liposomes (Lang et al., 2010) .
Histology
Histological analysis on snap frozen tissue was performed as previously described (Recher et al., 2007) by using CD8, F4/80, CD19 (eBioscience), alpha smooth muscle actin (Abcam), Qa-1b (BD Biosciences), and selfmade anti-LCMV monoclonal antibody (Clone: VL4).
ELISA IFN-a ELISA kit was purchased from PBL Biosciences. All experiments were performed according to the manufacturers' instructions.
Flow Cytometry Analysis
Experiments were performed using a FACS Fortessa and analyzed with FlowJo software. For ILC staining, single suspended cells were prepared and washed twice with PBS, incubated with fixable live/dead dye (eBioscience) and Fc block (eBioscience), and then stained with NKG2A/C/E(clone 20D5), CD3, CD5, CD19, Ly-6G, CD8, FceR1, TCRb, NK1.1, CD11b, CD45.2, CD90.2, CD4, RORgT, GATA-3, and EOMES, along with beads for cell counting (BD). Intracellular cytokine staining of ILCs was performed with a Foxp3 mouse regulatory T cell (Treg) staining buffer kit (eBioscience). Tetramer and intracellular cytokine staining were performed as described previously (Xu et al., 2014) . For tetramer staining, single suspended cells were incubated with tetramer-gp33 (CD8) for 15 min or incubated with tetramer-gp61 (CD4) for 30min at 37 C. After incubation, anti-CD8 (eBioscience) or anti-CD4 (eBioscience) surface antibodies were added for 30 min at 4 C. For intracellular cytokine re-stimulation, single suspended cells were stimulated with LCMV-specific peptide gp33 and gp61 for 1 hr, and Bredeldin A (eBiocience) was added for another 5-hr incubation at 37 C. A FACS Aria III was used for Flow Cytometry based cell sorting experiments.
NK Cell Purification and Culture
Single-cell suspended splenocytes were enriched following the manufacturer's instructions with the DX5 MACS kit (Miltenyi Biotec). Positively sorted NK cells were stimulated with 1,000 U/mL IL-2 (Miltenyi Biotec) for 4 days.
B Cell Purification
Single-cell suspended splenocytes were enriched following the manufacturer's instructions with the CD19 MACS kit (Miltenyi Biotec). Positively sorted CD19 + B cells were incubated with 100mg/mL Qdm peptide (AMAPRTLLL) for 24 hr.
In Vitro Flow-Cytometry-Based NK Killing Assay Negatively sorted CD8 + T cells were stimulated with 5 mg/mL Concanavalin A for 24 hr, and dead cells were removed by gradient centrifugation (Ficoll-Paque 1.084, GE Healthcare). Live activated CD8 + T cells were co-incubated with IL-2-derived NK cells and B cells at indicated effector-to-target ratio in the (G) ALT activity in the serum of NK cell-depleted or non-depleted control or Qa-1b À/À mice was determined at indicated time points (n = 8-10; *p < 0.05, **p < 0.01 between the control and Qa-1b À/À group; ### p < 0.001 between Qa-1b À/À and NK cell-depleted Qa-1b À/À animals). (H) Sections of snap frozen liver tissue were stained with a-smooth muscle actin (Alpha-SMA) antibody; 1 representative image of n = 8-10 is shown (scale bar indicates 100 mm). Error bars show SEM; *p < 0.05, **p < 0.01, ***p < 0.001; ns, not statistically significant between the indicated groups. See also Figure S6 . presence of 2 U/mL IL-2 for 4 hr. Dead CD8 + T cells were identified by 7-aminoactinomycin D (7AAD) staining. NK-specific killing was calculated by (% live T cells (without co-incubation with NK cells) -% live T cells (co-incubation with NK cells) )/ (% live T cells (without co-incubation with NK cells) ).
RNA Purification and RT-PCR RNA purification was performed according to the manufacturer's instructions (QIAGEN). Gene expression of H2-T23, H2-K1, Clec2d, Cd48, Cdh1, Col17a1, Cd70, Pvr, Icam1, Pvrl2, Slamf7, Ulbp1, Icam5, Rae1, Icam2, Vcam1, Cadm1, CD99, Cd23, and Gapdh were performed using a kit from Bio-Rad. For analysis, the expression levels of all genes were normalized to Gapdh (DCt [cycle threshold]). Then gene expression values were calculated based on the DDCt method relative to naive WT controls. Relative quantities (RQs) were determined using the equation: RQ = 2^-DDCt.
Statistical Analysis
Data are expressed as mean ± SEM. For analysis of statistical significance between two groups a Student's t test was used. For the analysis of multiple time points experiment, two-way ANOVA with an additional Bonferroni posttest was used; p < 0.05 was considered as statistically significant.
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